retatrutide latest trial results Results: 28.3% Weight Loss Data VisualAbstract: Retatrutide reduces body weight
Description
The popular drugs, originally developed to treat diabetes, were also associated with an improved survival rate
Orexigenic (AgRP/NPY) &
Obesity is a chronic condition
Medicaid policies on GLP-1 weight loss medications differ significantly across states, with many requiring prior authorization or limiting coverage to diabetes treatment
Genome-wide association study (GWAS) data for AF were sourced from FinnGen10, whereas data for cardiac arrest and ventricular fibrillation came from the GWAS Catalog
Reflections on Obesity, Dieting, and the New New Thing
